Literature DB >> 18505907

The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.

Nectaria Xita1, Ioannis Georgiou, Leandros Lazaros, Vasiliki Psofaki, George Kolios, Agathocles Tsatsoulis.   

Abstract

OBJECTIVE: Experimental evidence suggests that fetal exposure to androgen excess may program the development of polycystic ovary syndrome (PCOS) in utero. The aim of this study was to examine whether the sex hormone binding globulin (SHBG)(TAAAA)n and the cytochrome P450, family 19 (CYP19)(TTTA)n polymorphisms, known to influence sex hormone-binding globulin (SHBG) levels and aromatase activity respectively, play a synergistic role in the development of PCOS. DESIGN AND METHODS: We studied 180 women with PCOS and 160 healthy women of reproductive age. The body mass index (BMI) was recorded and the hormonal profile determined from the third to fifth day of menstrual cycle. DNA was extracted from blood leucocytes and the SHBG(TAAAA)n and CYP19(TTTA)n polymorphisms were genotyped.
RESULTS: Genotype analysis revealed 6 SHBG(TAAAA)n alleles with 6-11 repeats and 6 CYP19(TTTA)n alleles with 7-12 repeats. Women were subdivided into four groups: those with short SHBG (< or = 8 TAAAA repeats) and CYP19 alleles (< or = 9 TTTA repeats), those with short SHBG-long CYP19 alleles, those with long SHBG-short CYP19 alleles, and those with long SHBG and CYP19 alleles. Women with PCOS tended to have at greater frequency, long SHBG-short CYP19 alleles compared with controls (57.3 vs 42.4%, P=0.07). Importantly, PCOS women with long SHBG-short CYP19 alleles had the lowest SHBG levels (P=0.02) and the highest total testosterone (P=0.008), free androgen index (P=0.002), DHEAS (P=0.02), and testosterone/estradiol ratio (P=0.03), compared with those with other genotypes. This association was independent of age, BMI, and insulin resistance indexes.
CONCLUSION: We speculate that the SHBG and CYP19 genes may have a synergistic role in the developmental programming of PCOS, by affecting androgen bioavailability and aromatization respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505907     DOI: 10.1530/EJE-07-0905

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  10 in total

Review 1.  Understanding polycystic ovarian syndrome pathogenesis: an updated of its genetic aspects.

Authors:  A E Calogero; V Calabrò; M Catanuso; R A Condorelli; S La Vignera
Journal:  J Endocrinol Invest       Date:  2011-05-23       Impact factor: 4.256

Review 2.  Sex hormone-binding globulin genetic variation: associations with type 2 diabetes mellitus and polycystic ovary syndrome.

Authors:  C Chen; J Smothers; A Lange; J E Nestler; J F Strauss Iii; E P Wickham Iii
Journal:  Minerva Endocrinol       Date:  2010-12       Impact factor: 2.184

3.  Aromatase (CYP19) gene variants influence ovarian response to standard gonadotrophin stimulation.

Authors:  Leandros A Lazaros; Elissavet G Hatzi; Nectaria V Xita; Georgios V Makrydimas; Apostolos I Kaponis; Atsushi Takenaka; Ioannis P Kosmas; Nikolaos V Sofikitis; Theodoros I Stefos; Konstantinos A Zikopoulos; Ioannis A Georgiou
Journal:  J Assist Reprod Genet       Date:  2011-11-17       Impact factor: 3.412

4.  The association of aromatase (CYP19) gene variants with sperm concentration and motility.

Authors:  Leandros Lazaros; Nectaria Xita; Apostolos Kaponis; Elissavet Hatzi; Nicolaos Plachouras; Nicolaos Sofikitis; Konstantinos Zikopoulos; Ioannis Georgiou
Journal:  Asian J Androl       Date:  2011-01-10       Impact factor: 3.285

Review 5.  Polycystic ovary syndrome in the pediatric population.

Authors:  Andrew A Bremer
Journal:  Metab Syndr Relat Disord       Date:  2010-10       Impact factor: 1.894

6.  The ovarian response to standard gonadotrophin stimulation depends on FSHR, SHBG and CYP19 gene synergism.

Authors:  Leandros A Lazaros; Elissavet G Hatzi; Christina E Pamporaki; Prodromos I Sakaloglou; Nectaria V Xita; Sophia I Markoula; Theodoros I Stefos; Konstantinos A Zikopoulos; Ioannis A Georgiou
Journal:  J Assist Reprod Genet       Date:  2012-08-23       Impact factor: 3.412

Review 7.  Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology.

Authors:  Roshan Dadachanji; Nuzhat Shaikh; Srabani Mukherjee
Journal:  Genet Res Int       Date:  2018-02-18

Review 8.  Identifying genes associated with the development of human polycystic ovary syndrome.

Authors:  Salina Y Saddick
Journal:  Saudi J Biol Sci       Date:  2020-01-16       Impact factor: 4.219

Review 9.  Effect of Sex Hormone-Binding Globulin on Polycystic Ovary Syndrome: Mechanisms, Manifestations, Genetics, and Treatment.

Authors:  Chuan Xing; Jiaqi Zhang; Han Zhao; Bing He
Journal:  Int J Womens Health       Date:  2022-02-02

Review 10.  The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis.

Authors:  Hiral Chaudhary; Jalpa Patel; Nayan K Jain; Rushikesh Joshi
Journal:  J Ovarian Res       Date:  2021-09-26       Impact factor: 4.234

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.